Neutralising antibodies to interferon beta during the treatment of multiple sclerosis.
Giovannoni
G
G
Munschauer
F E
FE
Deisenhammer
F
F
D000906:Antibodies / Q000276:immunology*; D000921:Antibody-Producing Cells / Q000276:immunology; D000998:Antiviral Agents / Q000145:classification / Q000276:immunology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007118:Immunoassay; D016899:Interferon-beta / Q000145:classification / Q000276:immunology* / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D009500:Neutralization Tests; D017211:Treatment Failure
D000906:Antibodies; D000998:Antiviral Agents; D016899:Interferon-beta